727,046 Shares in Cantel Medical Corp. (NYSE:CMD) Acquired by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC purchased a new position in shares of Cantel Medical Corp. (NYSE:CMD) during the second quarter, Holdings Channel reports. The institutional investor purchased 727,046 shares of the company’s stock, valued at approximately $56,644,000. Cantel Medical Corp. comprises approximately 2.9% of Conestoga Capital Advisors LLC’s holdings, making the stock its 4th largest position.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. GW&K Investment Management LLC acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $30,121,000. Pennsylvania Trust Co acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $6,590,000. Integrated Investment Consultants LLC acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $161,000. US Bancorp DE acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $249,000. Finally, Legato Capital Management LLC acquired a new position in shares of Cantel Medical Corp. during the second quarter worth about $631,000. 83.39% of the stock is currently owned by hedge funds and other institutional investors.

Cantel Medical Corp. (CMD) traded down 1.10% on Friday, reaching $76.11. The company’s stock had a trading volume of 191,280 shares. Cantel Medical Corp. has a 1-year low of $64.75 and a 1-year high of $88.81. The company has a market capitalization of $3.16 billion, a price-to-earnings ratio of 45.04 and a beta of 1.24. The firm’s 50 day moving average price is $76.94 and its 200-day moving average price is $77.16.

Cantel Medical Corp. (NYSE:CMD) last issued its quarterly earnings results on Thursday, June 8th. The company reported $0.51 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.51. Cantel Medical Corp. had a return on equity of 17.75% and a net margin of 9.50%. The company had revenue of $192.10 million during the quarter, compared to analysts’ expectations of $193.84 million. The business’s quarterly revenue was up 10.6% on a year-over-year basis. Equities analysts forecast that Cantel Medical Corp. will post $2.06 earnings per share for the current year.

The company also recently declared a semiannual dividend, which will be paid on Monday, July 31st. Shareholders of record on Monday, July 17th will be given a dividend of $0.07 per share. The ex-dividend date is Thursday, July 13th. This represents a yield of 0.18%. Cantel Medical Corp.’s dividend payout ratio is currently 8.28%.

WARNING: “727,046 Shares in Cantel Medical Corp. (NYSE:CMD) Acquired by Conestoga Capital Advisors LLC” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this news story can be viewed at https://sportsperspectives.com/2017/07/23/727046-shares-in-cantel-medical-corp-nysecmd-acquired-by-conestoga-capital-advisors-llc.html.

A number of research analysts have recently issued reports on CMD shares. Zacks Investment Research downgraded Cantel Medical Corp. from a “hold” rating to a “sell” rating in a report on Monday, June 5th. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a report on Thursday, June 8th. Finally, Benchmark Co. downgraded Cantel Medical Corp. from a “buy” rating to a “hold” rating in a report on Friday, June 9th.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 35,000 shares of Cantel Medical Corp. stock in a transaction dated Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total transaction of $2,643,200.00. Following the completion of the sale, the chairman now owns 3,114,520 shares of the company’s stock, valued at approximately $235,208,550.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Charles M. Diker sold 13,000 shares of Cantel Medical Corp. stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $76.36, for a total value of $992,680.00. Following the sale, the chairman now directly owns 3,124,222 shares of the company’s stock, valued at approximately $238,565,591.92. The disclosure for this sale can be found here. Insiders own 14.90% of the company’s stock.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply